Skip to content

The feasibility study of Robot-assisted gastrectomy for patients with gastric cancer -Single institute prospective cohort study

The feasibility study of Robot-assisted gastrectomy for patients with gastric cancer -Single institute prospective cohort study - The feasibility study of Robot-assisted gastrectomy for patients with gastric cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000035459
Enrollment
20
Registered
2019-01-06
Start date
2018-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

None listed

Sponsors

Southern Tohoku General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients where a distal , pylorus preserving, proximal or total gastrectomy was planned, following by histologically confirmed gastric cancer (common type: pap, tub 1, tub 2, por 1, por 2, sig, muc) before surgery. 2. Patients of c Stage I gastric cancer (T1N0M0, T2N0M0, T1N1M0)

Exclusion criteria

Exclusion criteria: 1. Patients with remnant stomach cancer. 2. Patients who underwent radiotherapy or other cancer treatment before surgery. 3. Patients who are required comprehensive resection of the spleen or other organs. 4. Patients who undergo large invasive surgery such as colon cancer surgery. 5. Patients who cannot obtain informed consent to participate in this study. 6. Patients with esophageal invasion 7. Patients with duodenal invasion

Design outcomes

Primary

MeasureTime frame
Incident of postoperative complications beyond Clavien-Dindo IIIa.

Secondary

MeasureTime frame
1. All adverse events 2. Number of lymph node dissection 3. Surgical time (anesthesia time, operation time, console operation time, total time from entering operation room to leaving) 4. Bleeding volume 5. Intraoperative incident 6. Proportion of conversion to open surgery 7. Period up to the start of postoperative adjuvant chemotherapy 8. Hospitalization days 9. Cost

Countries

Japan

Contacts

Public ContactMichitaka Honda

Southern Tohoku General Hospital Surgery

mhonda@fukushimamed.com024-934-5322

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026